LEVODOPA COMBINED WITH MK 486 (L‐ALPHA METHYLDOPAHYDRAZINE)—A PERIPHERAL DECARBOXYLASE INHIBITOR IN PARKINSON'S DISEASE
- 1 March 1974
- journal article
- research article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 1 (12) , 429-432
- https://doi.org/10.5694/j.1326-5377.1974.tb50811.x
Abstract
A single blind trial using placebo MK 486 in seven patients over 12 weeks and active MK 486 (L‐alpha methyldopahydrazine) over 20 weeks in 12 Parkinsonian patients on L‐dopa therapy reveals that pati...Keywords
This publication has 5 references indexed in Scilit:
- Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylaseJournal of the Neurological Sciences, 1972
- Levodopa in Parkinsonism: Potentiation of Central Effects with a Peripheral InhibitorNew England Journal of Medicine, 1972
- Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with LevodopaBMJ, 1971
- Increase of Cerebral Catecholamines caused by 3,4-Dihydroxyphenylalanine after Inhibition of Peripheral DecarboxylaseNature, 1967
- Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen SystemsJournal of Molecular Medicine, 1960